SHE:300255 Revenue

Hebei Changshan Biochemical Pharmaceutical had revenue of 258.70M CNY in the quarter ending March 31, 2025, a decrease of -12.10%. This brings the company's revenue in the last twelve months to 995.20M, down -17.26% year-over-year. In the year 2024, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 1.03B, down -26.92%.

Revenue (ttm)

995.20M

Revenue Growth

-17.26%

P/S Ratio

22.52

Revenue / Employee

731.07K

Employees

1,410

Market Cap

23.22B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.03B	-379.63M	-26.92%
Dec 31, 2023	1.41B	-925.79M	-39.63%
Jan 1, 2023	2.34B	-631.82M	-21.29%
Jan 1, 2022	2.97B	604.26M	25.56%
Dec 31, 2020	2.36B	292.31M	14.11%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings